Showing results (71-80 of 3,346) with videos related to

Sort By:
Pageof 335
Pharmacoeconomics|November 30, 2002
Reimbursement and cost containment: a German perspectiveFriedrich Breyer
Pharmacoeconomics|December 18, 2002
Generic clozapine: a cost-saving alternative to brand name clozapine?Gordon Tse, Deborah Thompson, Ric M Procyshyn
Pharmacoeconomics|July 3, 2002
Cost effectiveness of paclitaxel/cisplatin compared with cyclophosphamide/cisplatin in the treatment of advanced ovarian cancer in BelgiumNiels Neymark, Thierry Gorlia, Ines Adriaenssen, et al.
Pharmacoeconomics|July 27, 2002
Cost effectiveness of treatment of Parkinson's disease with entacapone in the United StatesCynthia S Palmer, Mark J C Nuijten, Jordana K Schmier, et al.
Pharmacoeconomics|April 8, 2003
Cost-benefit model comparing two alternative immunisation programmes against serogroup C meningococcal disease: for Quebec residents aged 2 months to 20 yearsCarol Rancourt, Jean-Pierre Grégoire, W Simons, et al.
Pharmacoeconomics|November 10, 2001
Using health outcomes data to inform decision-making: a pharmaceutical industry perspectiveM Keech
Pharmacoeconomics|November 10, 2001
Using health outcomes data to inform decision-making: formulary committee perspectiveR Janknegt
Pharmacoeconomics|November 10, 2001
Using clinical measures of disease control to reduce the burden of asthmaE D Bateman
Pharmacoeconomics|February 26, 2003
Unit costs of inpatient hospital daysJan B Oostenbrink, Tineke Buijs-Van der Woude, Michel van Agthoven, et al.
Pharmacoeconomics|February 1, 2003
The burden of age-related macular degeneration: results of a cohort study in two French referral centresJulia Bonastre, Claude Le Pen, Gisèle Soubrane, et al.
Pageof 335